These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis. Nkyimbeng T; Ruppert C; Shiomi T; Dahal B; Lang G; Seeger W; Okada Y; D'Armiento J; Günther A PLoS One; 2013; 8(9):e73279. PubMed ID: 24023851 [TBL] [Abstract][Full Text] [Related]
6. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias. Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192 [TBL] [Abstract][Full Text] [Related]
7. Discovery of Aryloxyphenyl-Heptapeptide Hybrids as Potent and Selective Matrix Metalloproteinase-2 Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis. Takeuchi T; Hayashi M; Tamita T; Nomura Y; Kojima N; Mitani A; Takeda T; Hitaka K; Kato Y; Kamitani M; Mima M; Toki H; Ohkubo M; Nozoe A; Kakinuma H J Med Chem; 2022 Jun; 65(12):8493-8510. PubMed ID: 35687819 [TBL] [Abstract][Full Text] [Related]
8. Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases. Abd-Elaziz K; Jesenak M; Vasakova M; Diamant Z Curr Opin Pulm Med; 2021 Jan; 27(1):54-60. PubMed ID: 33065600 [TBL] [Abstract][Full Text] [Related]
15. Effects of doxycycline on production of growth factors and matrix metalloproteinases in pulmonary fibrosis. Fujita H; Sakamoto N; Ishimatsu Y; Kakugawa T; Hara S; Hara A; Amenomori M; Ishimoto H; Nagata T; Mukae H; Kohno S Respiration; 2011; 81(5):420-30. PubMed ID: 21502778 [TBL] [Abstract][Full Text] [Related]
16. Exploitation of Novel Molecular Targets to Treat Idiopathic Pulmonary Fibrosis: A Drug Discovery Perspective. Vaidya B; Patel R; Muth A; Gupta V Curr Med Chem; 2017; 24(22):2439-2458. PubMed ID: 28552057 [TBL] [Abstract][Full Text] [Related]
17. Is there new hope for therapeutic matrix metalloproteinase inhibition? Vandenbroucke RE; Libert C Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097 [TBL] [Abstract][Full Text] [Related]
18. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Beeh KM; Beier J; Kornmann O; Buhl R Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147 [TBL] [Abstract][Full Text] [Related]
19. Design and Structural Evolution of Matrix Metalloproteinase Inhibitors. Fischer T; Senn N; Riedl R Chemistry; 2019 Jun; 25(34):7960-7980. PubMed ID: 30720221 [TBL] [Abstract][Full Text] [Related]